Literature DB >> 28478494

The impact on cognitive functions of patients with pituitary adenoma before and after surgery.

Xianxiang Wang1, Xuanxia Tong2, Yanfeng Zou3, Xuefeng Tian1, Zhongxiang Mao1, Zhongwu Sun4.   

Abstract

Patients with pituitary adenoma have often suffered cognitive impairment. The study aims to identify the factors, and their impact, that affect the cognitive functions of pituitary adenoma patients. Seventy-six patients with pituitary adenoma were recruited, together with 76 healthy subjects as control. Patients (34 functioning and 42 non-functioning) were randomly assigned into either microscopic (n = 44) or neural endoscopic (n = 32) group. All surgeries were performed through single-nostril transsphenoidal approach under general anesthesia with endotracheal intubation. All patients were examined with cognitive assessments (CAMCOG-C and MMSE tests), tumor size, eyesight, and hormone levels before surgery. Three months after surgery, all patients were examined again to check hormone level changes by blood samples, tumor excision status via MRI, and cognitive assessments. Compared with healthy control, total score and multiple cognitive scores of CAMCOG-C and MMSE were significantly lower before surgery. There were no correlations between cognitive functions and tumor size or eyesight. Significant difference in cognitive functions was found between functioning and non-functioning pituitary adenoma patients. Significant increase in cognitive functions occurred after surgery, whereas no difference was detected between the two different surgical treatments. The hormone levels were improved significantly in patients with hormone disorders after surgery. The physical compression from tumor might not play a key role in cognitive impairment. However, hormone disorders could be a major factor to cognitive impairment. The improvement in cognitive functions is attributed to the amelioration of endocrine disorders. There were no differences between two surgical treatments.

Entities:  

Keywords:  Cognitive function; Hormone disorder; Pituitary adenoma; Tumor

Mesh:

Year:  2017        PMID: 28478494     DOI: 10.1007/s10072-017-2980-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Surgical management of pituitary adenomas.

Authors:  J A Jane; E R Laws
Journal:  Singapore Med J       Date:  2002-06       Impact factor: 1.858

2.  Radiation necrosis of the optic chiasm, optic tract, hypothalamus, and upper pons after radiotherapy for pituitary adenoma, detected by gadolinium-enhanced, T1-weighted magnetic resonance imaging: case report.

Authors:  O Tachibana; N Yamaguchi; T Yamashima; J Yamashita
Journal:  Neurosurgery       Date:  1990-10       Impact factor: 4.654

3.  Neuropsychological abnormalities in patients with pituitary tumours.

Authors:  P J Grattan-Smith; J G Morris; E A Shores; J Batchelor; R S Sparks
Journal:  Acta Neurol Scand       Date:  1992-12       Impact factor: 3.209

Review 4.  Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis.

Authors:  J K Goudakos; K D Markou; C Georgalas
Journal:  Clin Otolaryngol       Date:  2011-06       Impact factor: 2.597

5.  Lower urinary tract function in patients with pituitary adenoma compressing hypothalamus.

Authors:  T Yamamoto; R Sakakibara; T Uchiyama; Z Liu; T Ito; T Yamanishi; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

6.  [Trans-sphenoid surgery of pituitary adenoma: clinical anatomy].

Authors:  I Kato; S Nakai; T Terabayashi
Journal:  Nihon Jibiinkoka Gakkai Kaiho       Date:  1979-04-20

Review 7.  Management of aggressive growth hormone secreting pituitary adenomas.

Authors:  Daniel A Donoho; Namrata Bose; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

8.  Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas.

Authors:  Sarah M Leistner; Jens Klotsche; Christina Dimopoulou; Anastasia P Athanasoulia; Josefine Roemmler-Zehrer; Lars Pieper; Jochen Schopohl; Hans-Ulrich Wittchen; Günter K Stalla; Stephany Fulda; Caroline Sievers
Journal:  Eur J Endocrinol       Date:  2015-03-19       Impact factor: 6.664

Review 9.  Pituitary disorders. Drug treatment options.

Authors:  J J Orrego; A L Barkan
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 10.  Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment.

Authors:  G T Stebbins; C M Murphy
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more
  2 in total

1.  Endoscopic vs. microscopic transsphenoidal surgery outcomes in 514 nonfunctioning pituitary adenoma cases.

Authors:  Shuaihua Song; Linping Wang; Qianjin Qi; Haoran Wang; Li Feng
Journal:  Neurosurg Rev       Date:  2022-03-01       Impact factor: 3.042

2.  Hyperprolactinemia Associated with Attentional Processing and Interference Control Impairments in Patients with Prolactinomas.

Authors:  Aobo Chen; Chenglong Cao; Bangxin Liu; Shuochen Wang; Shukai Wu; Guozheng Xu; Jian Song
Journal:  Brain Sci       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.